Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

16.65 -0.13 (-0.77%)
Official Closing Price Updated: 7:00 PM EST, Dec 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Looking At Teva Pharmaceutical Indus's Recent Unusual Options Activity
Someone with a lot of money to spend has taken a bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA). And retail traders should know. We noticed this today when the big position showed up on... 
Via Benzinga
Is Prometheus Biosciences a Good Stock to Buy Right Now?
This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead. 
Via The Motley Fool
3 Unparalleled Stocks to Buy That Have Never Been This Cheap
These three leading companies are ripe for the picking and may never be this cheap again. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
4 Analysts Have This to Say About Teva Pharmaceutical Indus
Via Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
Via Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
Via Benzinga
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
Via Benzinga
Stocks Move Higher As Wall Street Eyes China Lockdowns
The Dow Jones Industrial Average is up 271 points midday, while the Nasdaq Composite and S&P 500 Index are firmly higher as well. 
Via Talk Markets
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. 
Via InvestorPlace
TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO
Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. 
Via InvestorPlace
Why Teva Stock Sank On Thursday
There were two major developments with the company, both of which involved piles of money. 
Via The Motley Fool
Teva Highlights Long-Term Data From Chorea Associated-Huntington's Treatment
Via Benzinga
AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at... 
Via Benzinga
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three... 
Via Benzinga
Adding $100 to These 5 Stocks Would Be a Genius Move Right Now
You don't need a large pile of cash to begin building wealth on Wall Street. 
Via The Motley Fool
Why Teva Stock Stumbled Again on Friday
A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments. 
Via The Motley Fool
Teva Pharmaceutical Industries (TEVA) Q3 2022 Earnings Call Transcript
TEVA earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Via Benzinga
Teva Pharmaceutical Posts Lower Q3 Sales & Profits, Trims FY22 Revenue Outlook
Via Benzinga
Recap: Teva Pharmaceutical Q3 Earnings
Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13
Reuters 
Via Benzinga
FDA Signals Shortage For Teva Pharma's ADHD Drug Due To Manufacturing Delay
The FDA said that there was a shortage of Adderall after intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (NYSE: TEVA). 
Via Benzinga
Teva Under Suspicion On Practices To Stave Off Copaxone Competition
The European Commission, in an interim view, says Teva Pharmaceutical Industries Ltd (NYSE: TEVA) breached European Union (EU) antitrust rules over practices delaying competition to the multiple... 
Via Benzinga
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
European Drug Makers Say Higher Energy Costs Eating Margins: Report
Europe's drug makers have warned about stopping manufacturing some cheap generic medicines amid surging electricity costs. 
Via Benzinga
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
Via Benzinga
Top Financial Media Stories Monday, September 19: Apple iPhone 14's Glitch With Some Third Party Apps, Tesla Wants To Double Sales In Germany, Ford Working On Smartphone Based Crash Detection Tech And More..
Reuters Volkswagen Eyes Juicy Valuations For Porsche IPO 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback